Biosimilar Clones

To enhance India’s biosimilar market and support complete indigenous development of biosimilars, (therapeutic proteins and monoclonal antibodies) National Biopharma Mission is supporting the development of clones preferably for those biosimilars with innovator patent expiry (US/EU) between 2020-2025.

Therapeutic Area/ Name of Product

Name of grantee

Development Phase Supported

Environmental and Health Risk Management Plan (EHRMP)

Cancer/Ramucirumab Enzene Biosciences Ltd Clone Development  Click Here
Cancer/Golimumab Genext Genomics Pvt Ltd Clone Development  Click Here
Emergency Situations/Factor VIII Vellore Institute of Technology & Amthera Lifesciences Pvt Ltd Clone Development

 Click Here
 Click Here